Loading page…
Find your medicineSearch name, salt, strength or type
Explore Curis Lifesciences products including Neptaz 50 mg and other pharmaceutical formulations, with clear information on active ingredients, strengths, dosage forms and therapeutic categories.
Curis Lifesciences is an Indian pharmaceutical manufacturing company involved in the development and manufacture of pharmaceutical formulations across multiple dosage forms and therapeutic areas. Its documented product portfolio includes pharmaceutical tablets, capsules, oral liquids, external preparations and sterile ophthalmic ointments. Curis Lifesciences operates across domestic and international markets and undertakes pharmaceutical manufacturing through contract manufacturing, loan-licence and own-brand arrangements.
Among the cardiovascular formulations associated with the Curis portfolio is the sacubitril and valsartan combination, including the 24 mg + 26 mg strength corresponding to Neptaz 50 mg. Curis's published pharmaceutical product documentation lists sacubitril and valsartan tablets in 24 mg + 26 mg and 49 mg + 51 mg strengths.
Curis Lifesciences has a broad pharmaceutical formulation portfolio rather than operating around a single therapeutic category. Its published product information covers general pharmaceutical tablets and capsules, oral liquids, external preparations and sterile ophthalmic ointments. The company's tablet portfolio includes medicines associated with cardiovascular care, pain management, infections, gastrointestinal conditions, neurological conditions, lipid management and other therapeutic areas.
Curis products with their active ingredients, medicine categories and educational information. Product availability should be determined from the individual product pages rather than assuming that every medicine in the manufacturer's broader portfolio is currently available.
When searching for a Curis Lifesciences medicine on KwickPharmacy, use the medicine's brand name, active ingredient or strength. For example, users looking for Neptaz 50 mg can search by the product name or by its composition, sacubitril 24 mg + valsartan 26 mg.
Each product page should provide the exact medicine name, active ingredients, strength, dosage form, manufacturer or marketer information where available, and relevant medicine information.
The fact that a medicine appears in a manufacturer's product portfolio does not mean that it is appropriate for every patient. Prescription medicines should be used only according to the advice of a qualified healthcare professional.
For medicines such as sacubitril/valsartan, the prescribed strength, treatment duration and combination with other medicines can vary according to the patient's medical circumstances. Patients should check the product label and prescription carefully and consult their doctor or pharmacist if they are unsure about the medicine.
Do not use manufacturer or product information as a substitute for individual medical advice.
Explore the available Curis Lifesciences products on KwickPharmacy and open each medicine page for its exact composition, strength, dosage form and medicine-specific information.
Curis's published pharmaceutical portfolio includes sacubitril and valsartan tablets containing 24 mg + 26 mg, the same active-ingredient strengths found in Neptaz 50 mg. Retail listings identify Mankind Pharma in connection with the Neptaz brand, while some trade listings use the designation Curis Mankind.